Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus.
prognostic factors
radical nephrectomy
renal tumor
tumor thrombus
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
21 Nov 2021
21 Nov 2021
Historique:
received:
02
10
2021
accepted:
20
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
The purpose of the study was to determine the influence of lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR) values on the prognosis in patients with renal cell carcinoma (RCC) and venous tumor thrombus. The respective data of 91 patients treated with radical surgery in the years 2012-2021 in 2 tertiary referral urological centers were retrieved from local medical databases. Mean calculated 3-year overall survival (OS) reached 70% (mean follow-up 35.3 months). The association between lower LMR and the presence of tumor necrosis (
Identifiants
pubmed: 34829506
pii: diagnostics11112159
doi: 10.3390/diagnostics11112159
pmc: PMC8623560
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical University of Warsaw
ID : none
Références
Eur Urol Focus. 2020 Jan 15;6(1):104-111
pubmed: 30206003
Tumour Biol. 2016 Apr;37(4):4613-20
pubmed: 26508025
Cureus. 2018 Jan 10;10(1):e2051
pubmed: 29541572
Br J Cancer. 2013 Mar 5;108(4):901-7
pubmed: 23385728
Urol Oncol. 2017 Apr;35(4):135-141
pubmed: 28233671
Ann Vasc Surg. 2010 Nov;24(8):1089-93
pubmed: 20471214
World J Surg Oncol. 2015 Feb 04;13:14
pubmed: 25650039
Biology (Basel). 2021 Apr 13;10(4):
pubmed: 33924623
Ther Adv Med Oncol. 2021 May 18;13:17588359211019642
pubmed: 34046089
J Urol. 2013 Dec;190(6):1999-2004
pubmed: 23831313
Urol Oncol. 2014 Oct;32(7):1041-8
pubmed: 25027686
J Urol. 2005 Jan;173(1):52-5
pubmed: 15592024
Clin Chim Acta. 2018 May;480:166-172
pubmed: 29462592
Arch Med Sci. 2017 Sep 21;16(5):1062-1071
pubmed: 32863995
J Urol. 2013 Feb;189(2):454-61
pubmed: 23041457
Br J Cancer. 2013 Jul 9;109(1):147-53
pubmed: 23778526
Cancer Manag Res. 2019 Jan 18;11:909-919
pubmed: 30697081
Cancer. 2007 Jan 15;109(2):205-12
pubmed: 17149754
Int Braz J Urol. 2016 Jul-Aug;42(4):678-84
pubmed: 27564277
Medicine (Baltimore). 2018 Nov;97(48):e13433
pubmed: 30508956
Carcinogenesis. 2009 Jul;30(7):1073-81
pubmed: 19468060
Br J Urol. 1987 May;59(5):390-5
pubmed: 3594097
Int J Urol. 2015 Jun;22(6):534-9
pubmed: 25808349
Indian J Surg Oncol. 2017 Mar;8(1):14-18
pubmed: 28127177
World J Urol. 2017 Feb;35(2):261-270
pubmed: 27255479